Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Will Bitgo Btgo Stock Miss Expectations Price At 8.50 Up 1.31 20260402 AGRZ Agroz management flags targeted supply chain investments to lift future operating margin performance What Delta Air DAL management is not saying enough about Slight Loss 20260511 AvalonBay Communities Inc AVB Q1 2026 Earnings Preview Steady Execution Amid Multifamily Sector Inflection Point Autonomix AMIX Stock Forming Reversal 197 20260420 Universal UHT Falls 123 Watching 3825 Support 20260515 Bluejay Diag BJDX Q4 2023 Earnings Miss Sparks Concern Hindustan Copper Reports Strong Q4 Results Net Profit Surges 134 YoY Revenue Jumps 58 Kartoon Studios TOON Drops 340 Key Support at 060 20260515 Uber and Lyft Quarterly Revenue Comparison Diverging Trajectories in RideHailing Market Intelligent NBFCs Are Reshaping Indias Credit Landscape Through AIDriven Lending Jamie Dimon Signals Challenges Ahead for JPMorgan Bankers Zscaler Shares Plunge Over 30 as Downbeat Revenue Outlook Surprises Investors Wall Street Edges Higher as Mideast Peace Prospects Bolster Investor Sentiment Ponyai Assures Operations Unaffected by SelfDriving Car Safety Review ASR Q1 2026 Earnings EPS Misses Estimates Shares Dip 225 Northfield Bancorp Inc NFBK Q1 2026 Earnings EPS Beat Sends Shares Slightly Lower Amid Cautious Outlook NFG Q1 2026 Earnings EPS Misses Estimates as Stock Edges Lower American Financial Group Q1 2026 Earnings EPS Misses Estimates Amid Premium Growth Headwinds Paycom Q1 2026 Earnings EPS Tops Estimates Stock Slips Despite Strong Performance ANET Q1 2026 Earnings EPS Surpasses Estimates Shares Rise iQIYI Rebounds Sharply Testing Key Resistance Levels NXP Semiconductors NXPI Holds Steady Near Support After Minor Pullback KALA Bio Dips 65 Support Test Looms as Biotech Faces Pressure UMH Properties Inc UMH Sees Modest Decline as Shares Hold Above Key Support Replimune Group REPL Slides 644 as Biotech Shares Face Renewed Pressure